Behind the trust: International Biotechnology Trust plc
Biotech companies stand to inject high returns and positive social impact into an investor’s portfolio and International Biotechnology Trust has an impressive track record of doing this with lower volatility than the index (NASDAQ Biotechnology Index), while paying a healthy dividend yield...
Investing in biotechnology with investment trusts
How investment trusts can provide investors with access to the high-growth biotech sector…
Talking Trusts: An introduction to investing in biotech with International Biotechnology Trust
We talk about what IBT offers for investors looking for exposure to the biotech sector…
International Biotechnology Trust
19 Mar, 12:00
19 Mar, 12:00
Computer says no
Markets are fixated on replacing humans with AI, rather than maintaining them with biotech. Could this be an opportunity to rotate profits?
Staying on course in a volatile sector
IBT's has delivered superior returns with lower volatility than the wider market...
Healthcare and biotech are out of favour despite the secular growth trends supporting them…
A biotech bounce back? With IBT Manager Ailsa Craig - Podcast: Trust Issues #22
We talk the move to Schroders, managing risk, and reinvesting the proceeds of M&A activity...
IBT managers’ unique approach set to continue at Schroders…
The first course: week one of our ISA event in review
We look at the first four presentations of our ISA season event…
The middle ground is not middle of the road in biotechnology
While the sell-off in tech has driven generalist investors into larger-cap biotechnology names, the managers of IBT have been focusing their attention on mid-caps…
International Biotechnology Trust - Harnessing healthcare for growth and income
Recorded 9 Mar 2023
Recorded 9 Mar 2023
Solving the Rubik’s Cube
We reveal the winners of our investment trust ratings for 2023…
Here we go again
We review our ‘top picks’ for what was a wild year and place our bets for the year ahead – which doesn’t look much calmer…
Podcast: Trust Issues #8 - Biotech investing in 2023 with IBT managers
Ailsa Craig and Marek Poszepczynski update us on goings on in the biotech industry...
As the year draws to its close, our analysts highlight the articles they think are the team’s best calls from 2022…
Have the engines started for the next mergers & acquisitions cycle?
Will the recent uptick in the share prices of mega-cap biotechs spread to the rest of the sector…
Five alternative trusts for income investors
Slides and audio from our event last week, featuring five trust managers discussing different strategies to deliver income for shareholders in challenging market conditions...
Slides and Audio: International Biotechnology
Download the presentation and listen to the audio from our 'Alternatives for income investors' virtual week from 25 May...
The inevitabilities: death and taxes
Biotech has had a rough ride lately but, as the world gets older and richer, our analysts think long-term secular growth is inevitable…
Five trusts to diversify your portfolio income
Join us next week for one live webinar with a different manager every day of the week – including the chance to ask questions - focused on different solutions for those seeking a decent income…